Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR10842356

b6b47534-acd5-5a94-9e1b-9962410deb52

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype

GSVA pathway preview (0 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

No GSVA scores available for this sample.

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

7 twins match this tumor's tissue · 3 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1TCGA-GM-A2DM-01A-11R-A180-07
breast-umap@18
B0.745
2ERR2208942
melanoma-umap@29
0.707
3MDT-AP-2744
medullo-epn-umap@date-based
MedMedulloblastoma0.673
4MDT-AP-2996
medullo-epn-umap@date-based
MedMedulloblastoma0.673
5TCGA-86-8056-01A-11R-2241-07
lung-landscapes@6
cohortA10.656
6BS_9M5XJ10G
medullo-epn-umap@date-based
MedMedulloblastoma0.645
7TCGA-CV-6953-01A-11R-1915-07
head-neck@1
0.643
8SRR8518177
breast-umap@18
F0.643
9TCGA-J2-8194-01A-11R-2241-07
lung-landscapes@6
cohortA20.642
10SRR8518157
breast-umap@18
F0.642

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 19 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
PROTEIN_SECRETION0.400Remibrutinib— uncovered
REACTIVE_OXYGEN_SPECIES_PATHWAY0.300Inavolisib— uncovered
UNFOLDED_PROTEIN_RESPONSE0.300Idelalisib— uncovered
ANDROGEN_RESPONSE0.200Inavolisib— uncovered
ADIPOGENESIS0.100Inavolisib— uncovered
APOPTOSIS0.100Idelalisib— uncovered
COMPLEMENT0.100Inavolisib— uncovered
DNA_REPAIR0.100Idelalisib— uncovered
GLYCOLYSIS0.100Inavolisib— uncovered
HEME_METABOLISM0.100Temsirolimus— uncovered
HYPOXIA0.100Idelalisib— uncovered
IL6_JAK_STAT3_SIGNALING0.100Inavolisib— uncovered
KRAS_SIGNALING_UP0.100Inavolisib— uncovered
P53_PATHWAY0.100Idelalisib— uncovered
PEROXISOME0.100Idelalisib— uncovered
PI3K_AKT_MTOR_SIGNALING0.100Inavolisib— uncovered
TGF_BETA_SIGNALING0.100Inavolisib— uncovered
TNFA_SIGNALING_VIA_NFKB0.100Inavolisib— uncovered
UV_RESPONSE_UP0.100Idelalisib— uncovered